Babak Alipanahi
@babaka.bsky.social did:plc:5r7ah5acs63uvxfbfyknk6js
computational biology, artificial intelligence and large-scale datasets to improve human health
Bluesky’a katılma tarihi:
- Takipçi
- 1.139
- Takip edilen
- 323
- Post
- 87
- Sıralamaya girdiği gün
- 0
Özet
Babak Alipanahi (@babaka.bsky.social), 9 Ekim 2023 tarihinde katılan bir Bluesky kullanıcısı. 1.139 takipçisi var, 323 hesabı takip ediyor ve 87 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
A new feature @science.org on the clusters of cells that enhance the spread of cancer, and what can be done to break them up www.science.org/content/arti...
Postu gösterWere you inspired by our paper on the genetics of GLP-1 drug response? www.nature.com/articles/s41... Want to make impactful discoveries with the world's best genetic dataset? We're hiring! StatGen: tinyurl.com/ys4mvhej Risk Prediction: tinyurl.com/psamt294 Data Products: tinyurl.com/2ff7eavb
Postu gösterGLP-1 weight loss drugs come with a major caveat: They don’t work for everyone. A new study finds that part of the reason people’s responses to the drugs vary so widely may be in their DNA.
Postu gösterSpecific changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs used to treat obesity — and whether the drugs will cause nausea or vomiting. www.statnews.com/2026/04/08/2...
Postu gösterScientists have identified a set of genetic variants that could help to explain why responses to obesity drugs vary markedly from person to person go.nature.com/4ccK07M
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
